Masi Dina
SEC insider (Form 3/4/5 filer). CIK 0001345281. Chief Financial Officer at INTEGRATED BIOPHARMA INC (INBP). 6 reported Form 4/5 transactions since Sep 2024; latest on Dec 9, 2025. Located in HILLSIDE, NJ.
Companies Masi Dina has filed insider reports for
- INTEGRATED BIOPHARMA INC (INBP): Officer, Chief Financial Officer
Masi Dina
CIK: 0001345281
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INTEGRATED BIOPHARMA INC
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Dec 9, 2025INBP
INTEGRATED BIOPHARMA INC
AwardDirectStock Option (Right to Buy)
140K shares- - May 21, 2025INBP
INTEGRATED BIOPHARMA INC
AwardDirect135K shares at avg. $0.09$12K - May 21, 2025INBP
INTEGRATED BIOPHARMA INC
DispositionDirectStock Option (right to buy)
135K shares- - Dec 4, 2024INBP
INTEGRATED BIOPHARMA INC
AwardDirectStock Option (right to buy)
125K shares- - Nov 25, 2024INBP
INTEGRATED BIOPHARMA INC
AwardDirect65K shares at avg. $0.09$6K - Nov 25, 2024INBP
INTEGRATED BIOPHARMA INC
DispositionDirectStock Option (right to buy)
65K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 9, 2025 | INBP INTEGRATED BIOPHARMA INC | Award Stock Option (Right to Buy) | 140,000 | - | - | Direct |
| May 21, 2025 | INBP INTEGRATED BIOPHARMA INC | Award | 135,000 | $0.09 | $12,150 | Direct |
| May 21, 2025 | INBP INTEGRATED BIOPHARMA INC | Disposition Stock Option (right to buy) | 135,000 | - | - | Direct |
| Dec 4, 2024 | INBP INTEGRATED BIOPHARMA INC | Award Stock Option (right to buy) | 125,000 | - | - | Direct |
| Nov 25, 2024 | INBP INTEGRATED BIOPHARMA INC | Award | 65,000 | $0.09 | $5,850 | Direct |
| Nov 25, 2024 | INBP INTEGRATED BIOPHARMA INC | Disposition Stock Option (right to buy) | 65,000 | - | - | Direct |
1-6 of 6 transactions